Four (4) PhD Positions, ETN MAGICBULLET “Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy”, Europe (2015)

Applications are invited for 4 PhD positions (Early Stage Researchers (ESRs)) to be funded by the Marie Sklodowska-Curie Innovative Training Network “MAGICBULLET”.
The ESR positions are available at the following institutions:

- Bielefeld University, Bielefeld, Germany
- Università degli Studi dell’Insubria, Como, Italy
- Eötvös Lorand University, Budapest, Hungary
- University of Helsinki, Helsini, Finland
- Universita’ degli Studi di Milano, Milano, Italy
- University of Cologne, Cologne, Germany
- National Institute of Oncology, Budapest, Hungary
- Heidelberg Pharma, Ladenburg, Germany
- Exiris, Roma, Italy

The ETN MAGICBULLET will focus on chemistry-driven approaches toward conjugates between peptides (delivery vectors) that recognize tumors and anticancer drugs (payloads or warheads) in order to selectively fight cancer, a topic with a high demand of research activities.

The MAGICBULLET consortium brings together seven academic research groups from Germany (N. Sewald, Bielefeld and I. Neundorf, Cologne), Italy (C. Gennari, Milano and U. Piarulli, Como), Hungary (G. Mezö, Budapest and J. Tóvari, Budapest), and Finland (P. Laakkonen, Helsinki), and two pharmaceutical companies (Heidelberg Pharma, Ladenburg/Germany and Exiris, Rome/Italy) who will join forces to develop new chemistry-driven concepts for anti-tumour therapies.

The ETN MAGICBULLET will be supported by Bayer Pharma AG, Wuppertal/Germany, the Optical Imaging Centre Erlangen/Germany, Kineto Lab, Budapest/Hungary, Fraunhofer ITEM, Hannover/Germany, and IRBM, Pomezia/Italy as Partner Organzations. The partners will offer secondments to all ESRs recruited by the ETN to support the development of their research projects.

Further details:
http://academicpositions.eu